About Dechra Pharmaceuticals plc
Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Genera and Dechra Pharmaceuticals Manufacturing. It manufactures and markets Companion Animal, Equine and Food producing Animal Products. It includes third party manufacturing and other non-core activities sales. The NA Pharmaceuticals Segment consists of Dechra Veterinary Products US, Putney, Dechra Veterinary Products Canada, and Dechra-Brovel that sell Companion Animal and Equine Products into those territories. The Pharmaceuticals Research and Development Segment includes its pharmaceutical research and development activities. Its offerings include Osphos and Vetoryl.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: LON
- Symbol: DPH
- Previous Close: $19.16
- 50 Day Moving Average: $1469.38
- 200 Day Moving Average: $1367.23
- 52-Week Range: GBX 811 - GBX 1,582
- Trailing P/E Ratio: 109.22
- P/E Growth: 1.59
- Market Cap: $1.43B
- Outstanding Shares: 92,744,000
What is Dechra Pharmaceuticals plc's stock symbol?
Dechra Pharmaceuticals plc trades on the London Stock Exchange (LON) under the ticker symbol "DPH."
How often does Dechra Pharmaceuticals plc pay dividends? What is the dividend yield for Dechra Pharmaceuticals plc?
Dechra Pharmaceuticals plc announced a dividend on Monday, September 5th. Shareholders of record on Thursday, October 27th will be paid a dividend of GBX 12.91 per share on Friday, November 18th. This represents a yield of 0.92%. The ex-dividend date of this dividend is Thursday, October 27th. This is a positive change from Dechra Pharmaceuticals plc's previous dividend of $5.55. The official announcement can be viewed at this link.
Where is Dechra Pharmaceuticals plc's stock going? Where will Dechra Pharmaceuticals plc's stock price be in 2017?
6 equities research analysts have issued 1-year price targets for Dechra Pharmaceuticals plc's stock. Their predictions range from GBX 1,140 to GBX 1,520. On average, they expect Dechra Pharmaceuticals plc's share price to reach GBX 1,337.43 in the next year.
When will Dechra Pharmaceuticals plc announce their earnings?
Dechra Pharmaceuticals plc is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
How do I buy Dechra Pharmaceuticals plc stock?
Shares of Dechra Pharmaceuticals plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Dechra Pharmaceuticals plc stock cost?
One share of Dechra Pharmaceuticals plc stock can currently be purchased for approximately GBX 1,540.